Select Language

HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV)

HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV) Product List

Product Category
Protein (2)
Product Status
Launched (2)
Species
Human (2)
Tag
His Tag & Avi Tag (1)His Tag (1)
Conjugate
Biotin-labeled (1)PE Labeled (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature
HLC-H82E8	Human	HEK293	Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Monomer, MALS verified)
HLC-HP2H3	Human	HEK293	PE-Labeled Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Tetramer Protein

Total: 2

HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV) Background

The peptide LLDFVRFMGV, derived from the Epstein-Barr virus nuclear antigen EBNA3C, is presented by the HLA-A*02:01/β2m complex. This peptide-MHC complex serves as a major target for cytotoxic T lymphocytes (CTLs) in the immune control of EBV infection. Its robust immunogenicity makes it a key antigen of interest for studying EBV-specific T-cell responses and for developing immunotherapies against EBV-associated diseases.